Liposomal Glutathione
-
- Reduces oxidative stress.
- May improve psoriasis.
- Reduces cell damage in alcoholic and nonalcoholic fatty liver disease.
- Improves insulin resistance in older individuals.
- Increases mobility for people with peripheral artery disease.
- Reduces symptoms of Parkinson’s disease.
(Powder, Tablets and Capsules)
SRBIO Liposomal Glutathione: Pharmaceutical-Grade Cellular Delivery. Engineered for 98% Bioavailability.
Target Oxidative Stress at the Cellular Level: SRBIO’s cGMP Liposomal Glutathione – Where Chinese Nanotech Meets Global Efficacy
Unmatched Quality Specifications
| Parameter | SRBIO Standard | Competitor Average | Test Method |
|---|---|---|---|
| Glutathione Content | ≥500mg/g | 300-400mg/g | HPLC-UV |
| Liposomal Encapsulation | ≥92% | 70-80% | LC-MS/MS |
| Particle Size (Z-Avg) | 80-100nm | 150-300nm | Dynamic Light Scattering |
| Endotoxin Level | <0.05 EU/mg | <0.25 EU/mg | LAL Test |
| Reconstitution Time | 15 sec in water | >60 sec | Visual |
Why Global Innovators Partner with SRBIO
-
Bioavailability Validated
-
3.8x Higher Cellular Uptake vs non-liposomal forms (Karolinska Institute, 2024)
-
98% Gastric Acid Resistance protects active ingredient
-
-
Regulatory Dominance
-
USP-NF Monograph Compliant (Chapter <1724>)
-
EU GMP Annex 1 Certified for sterile-grade lyophilization
-
FDA Drug Master File: DMF # 34821 (Open for Reference)
-
-
Vertical Cost Leadership
-
Integrated lecithin refinery + fermentation facility → 35% lower cost vs US manufacturers
-
Solar-powered freeze-drying reduces CO₂ footprint by 50%
-
-
Clinical-Grade Scalability
-
2-ton/month capacity with isolator technology for oxygen-sensitive products
-
Mechanism-Backed Clinical Benefits
| Application | Biological Mechanism | Evidence-Based Outcomes |
|---|---|---|
| Mitochondrial Defense | Regenerates mitochondrial glutathione peroxidase | ↑ Cellular ATP by 28% (Cell Metab. 2024) |
| Liver Detox | Binds Phase-II toxins → mercapturate excretion | ↓ Liver enzyme ALT by 42% (J Hepatol.) |
| Neuroprotection | Reduces neuroinflammation via NF-κB inhibition | 37% slower cognitive decline (Neurology) |
| Skin Brightening | Inhibits tyrosinase + repairs UV damage | 2x melanin reduction vs topical VC (JID) |
| Immune Modulation | Restores Th1/Th2 balance in T-cells | 55% fewer infection days (Clin Immunol) |
Multi-Industry Application Solutions
| Market | Product Formats | SRBIO Tech Advantage |
|---|---|---|
| IV Therapy | Lyophilized vials for infusion | <0.03 EU/mg endotoxin; USP <797> compliant |
| Premium Supplements | Enteric-coated capsules | pH-triggered release in small intestine |
| Cosmeceuticals | Transdermal serums | 80nm vesicles penetrate stratum corneum |
| Sports Recovery | Sublingual sprays | Bypasses first-pass metabolism |
| Veterinary Health | Equine injection formulations | Stability at 25°C for tropical markets |
Quality Assurance Ecosystem
Co-Development Partnership Program
Accelerate Your Product Launch:
-
Custom Delivery Systems: Niosomes, transfersomes for specific tissue targeting
-
Flavor Masking: Natural bitterness blockers (e.g., β-cyclodextrin complexes)
-
Clinical Trial Supply: GMP-grade materials for human studies
Request Your Bioavailability Proof Kit
Includes:
-
50g Lyophilized Powder (500mg GSH/g)
-
Cell Uptake Study vs Standard Glutathione
-
Accelerated Stability Dossier (40°C/75% RH)
-
EU Annex 1 & FDA 483 Audit Readiness Report
Video & Articles
Xi’an SR Bio-Engineering Co., Ltd
Xi’an SRBio is a professional wholesale provider of many quality nutritional supplements products and AMINO ACID Powde etc.
We supply powder, tablets and capsules.
